氧/氧化双释放纳米酶用于增强TMZ介导的亡和亡
Jun Ma1, Jingjing Qiu2, Gus A Wright3
1Department of Biomedical Engineering, Texas A&M University, College Station, Texas 77843, United States.
Molecular pharmaceutics
|November 21, 2024
概括
这项研究引入了一种新的纳米粒子,可以为质母细胞瘤提供化疗. 纳米粒子释放氧气和氧化,通过向癌细胞和克服瘤缺氧,提高治疗效率.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 多形质母细胞瘤 (GBM) 是一种具有不良结果的侵袭性脑瘤.
- 标准化疗 (Temozolomide - TMZ) 由于向不良和瘤缺氧,有效性有限.
- 瘤微环境 (TME) 中的缺氧阻碍了化疗的有效性.
研究的目的:
- 开发一种双释放气体,癌细胞膜伪装的纳米粒子,用于有针对性的TMZ输送.
- 为了研究纳米粒子在TME中释放氧气 (O2) 和氧化 (NO) 的能力.
- 评估TMZ输送和气体释放对GBM的联合治疗效果.
主要方法:
- 开发的癌细胞膜伪装纳米 (CCM-CeO2) 装载着TMZ.
- 作为对TME条件 (H2O2) 的反应,研究了O2和NO释放机制.
- 评估了纳米粒子透到GBM球体和对HIF-1α表达的影响.
- 评估了体外抗瘤活性和IC50值.
主要成果:
- CCM-CeO2 证明了向的 GBM 细胞递送和 lysosomal 积累.
- 纳米颗粒释放了O2和NO,降低了GBM球体中的HIF-1α蛋白表达.
- 载有TMZ的CCM-CeO2增强了细胞内活性氧物种 (ROS),导致亡和亡的增加.
- 在体外测试显示TMZ的IC50值显著降低.
结论:
- 缓解瘤缺氧和增加ROS是GBM治疗的有效策略.
- 开发的CCM-CeO2纳米粒子系统显示了增强TMZ化疗在GBM中的前景.
- 这种方法为攻击性脑瘤提供了潜在的新治疗途径.
关键词:
细胞亡和亡.癌症细胞膜中的癌症细胞膜.lysosome 溶解酶体是如何形成的纳米纤维的使用方法氧化氧化是什么?氧气 氧气 氧气 氧气有活性氧物种的反应性氧物种.泰莫索洛米德 (temozolomide) 是一种有毒的物质.更多相关视频
06:58Synthesis of an In vivo MRI-detectable Apoptosis Probe
Published on: July 31, 2012
9.1K
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
相关概念视频
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:46Electron Transport Chain: Complex I and II
11.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.7K
01:16Necrosis
4.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K